Before you sell to, join or invest in AiTA Bio Inc.
MentionFox check on AiTA Bio Inc.: only 1 source on file so far (checked 6 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/aita-bio-inc-form-d-25000001
Check AiTA Bio Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
AiTA Bio Inc. filed a Form D with the Securities and Exchange Commission on 2025-01-14.
AiTA Bio Inc. filed a Form D notice of an exempt securities offering with the SEC on January 14, 2025. The filing reports $10M sold. Its industry group is Manufacturing. It names Jacob Menture (Chief Executive Officer, Director), Dilan Casanovas (Chief Operating Officer, Director) (SEC Form D, January 14, 2025).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like AiTA Bio Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-01-14 · the record
Pitching, partnering or investing alongside them? See who really runs and owns AiTA Bio Inc.
Free to see. No signup.
More on the people and the money behind AiTA Bio Inc., from the filings we hold.
Manufacturing raises by companies based in New York, filed within 90 days of this one, largest first.
Get an email when AiTA Bio Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when AiTA Bio Inc. raises, hires or launches. No email unless you switch it on.
Watch AiTA Bio Inc. →Get the full cited report on AiTA Bio Inc.
What the filing shows about AiTA Bio Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on AiTA Bio Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives AiTA Bio Inc.'s address as 139 5TH Avenue, Floor 5, New York, NY 10010.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
AiTA Bio Inc. is a registered filer with the SEC (CIK 2051873) and has filed since 2025-01-14. 1 filing is on record, the latest on 2025-01-14.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
AiTA Bio Inc.'s Form D of 2025-01-14 names Jacob Menture and Dilan Casanovas as its officers, directors or promoters.
Its new offerings report $10M sold across 1 offering, as its own filings state.
Trailing twelve months. 364 filings in Manufacturing, totalled by week.
On the filing as: Executive Officer, Director, Promoter.
Jacob Menture is named as Chief Executive Officer, Director on the Form D that AiTA Bio Inc. filed with the SEC on 14 January 2025, one of 2 people that filing names.
On the filing as: Executive Officer, Director.
Dilan Casanovas is named as Chief Operating Officer, Director on the Form D that AiTA Bio Inc. filed with the SEC on 14 January 2025, one of 2 people that filing names.
2 people named on the filing — 2 holding an executive role.
Named as of the 2025-01-14 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about AiTA Bio Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on AiTA Bio Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on AiTA Bio Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist AiTA Bio Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind AiTA Bio Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for AiTA Bio Inc.. With no account yet, you sign up free and land on the result.
On these lists: Manufacturing raises in New York
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/aita-bio-inc-form-d-25000001